Tenaya Therapeutics, Inc. (TNYA)
TNYA Stock Price Chart
Explore Tenaya Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze TNYA price movements and trends.
TNYA Company Profile
Discover essential business fundamentals and corporate details for Tenaya Therapeutics, Inc. (TNYA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
30 Jul 2021
Employees
70.00
CEO
Faraz Ali
Description
Tenaya Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. Its lead product candidate includes TN-201, a gene therapy for myosin binding protein C3-associated hypertrophic cardiomyopathy that is in Phase 1b/2 clinical trial; TN-401, a gene therapy for plakophilin 2-associated arrhythmogenic right ventricular cardiomyopathy, which is in Phase 1b/2 clinical trial; and TN-301, a small molecule histone deacetylase-6 for heart failure with preserved ejection fraction that is in phase 1 clinical trial. The company develops its products through gene addition, gene editing, gene silencing, and cellular regeneration. It has a research collaboration agreement with Alnylam Pharmaceuticals, Inc. to identify and validate novel gene targets for the potential treatment of cardiovascular disease. Tenaya Therapeutics, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.
TNYA Financial Timeline
Browse a chronological timeline of Tenaya Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 Aug 2026
EPS estimate is -$0.08, while revenue estimate is $10.00m.
Earnings released on 6 May 2026
EPS came in at -$0.09 matching the estimated -$0.09, while revenue for the quarter reached $225.00k , missing expectations by -97.00%.
Earnings released on 11 Mar 2026
EPS came in at -$0.12 surpassing the estimated -$0.13 by +7.69%.
Earnings released on 10 Nov 2025
EPS came in at -$0.12 surpassing the estimated -$0.15 by +20.00%.
Earnings released on 6 Aug 2025
EPS came in at -$0.14 surpassing the estimated -$0.20 by +30.00%.
Earnings released on 7 May 2025
EPS came in at -$0.24 falling short of the estimated -$0.18 by -33.33%.
Earnings released on 10 Mar 2025
EPS came in at -$0.28 surpassing the estimated -$0.31 by +9.68%.
Earnings released on 6 Nov 2024
EPS came in at -$0.30 surpassing the estimated -$0.37 by +18.92%.
Earnings released on 8 Aug 2024
EPS came in at -$0.34 surpassing the estimated -$0.40 by +15.00%.
Earnings released on 14 May 2024
EPS came in at -$0.40 surpassing the estimated -$0.43 by +6.98%.
Earnings released on 18 Mar 2024
EPS came in at -$0.40 surpassing the estimated -$0.45 by +11.11%, while revenue for the quarter reached $17.66m .
Earnings released on 8 Nov 2023
EPS came in at -$0.39 surpassing the estimated -$0.47 by +17.02%.
Earnings released on 9 Aug 2023
EPS came in at -$0.45 surpassing the estimated -$0.51 by +11.76%.
Earnings released on 10 May 2023
EPS came in at -$0.43 surpassing the estimated -$0.60 by +28.33%.
Earnings released on 8 Mar 2023
EPS came in at -$0.61 surpassing the estimated -$0.66 by +7.58%.
Earnings released on 10 Nov 2022
EPS came in at -$0.74 falling short of the estimated -$0.64 by -15.62%.
Earnings released on 10 Aug 2022
EPS came in at -$0.69 surpassing the estimated -$0.75 by +8.00%.
Earnings released on 11 May 2022
EPS came in at -$0.75 falling short of the estimated -$0.62 by -20.97%.
Earnings released on 23 Mar 2022
EPS came in at -$0.63 falling short of the estimated -$0.57 by -10.53%.
Earnings released on 10 Nov 2021
EPS came in at -$0.68 surpassing the estimated -$0.81 by +16.05%.
Earnings released on 8 Sept 2021
EPS came in at -$13.26 falling short of the estimated -$7.17 by -84.94%.
Earnings released on 30 Jul 2021
EPS came in at -$0.48 .
TNYA Stock Performance
Access detailed TNYA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
